Sage Journals: Discover world-class research

Free access

Review article

First published 2018-10

The role of emicizumab,a bispecific factor IXa- and factor X-directed antibody,for the prevention of bleeding episodes in patients with hemophilia A

Tristan Knight, Michael U. Callaghan

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2025

The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies

Yong jun Bae, Houry Leblebjian, Robert Redd [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2018-9

Bispecific Playgrounds? No,Factory Floors

Patricia Fitzpatrick Dimond

Genetic Engineering & Biotechnology News

Retricted access

Research article

First published 2009-04

111 In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor,p27 Kip1

Bart Cornelissen, Veerle Kersemans, Kristin McLarty [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2022

On Morphisms Preserving Palindromic Richness

Francesco Dolce, Edita Pelantová

Fundamenta Informaticae

Retricted access

Letter

First published 2026-4

Comments on “The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies”

Ankur Sharma, Sushma Narsing Katkuri, Varshini Vadhithala [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2021-03-23

Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein

Wim Hendricus Quint, Irena Matečko-Burmann, Irene Schilcher [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2025

Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis

Yueying Chen, Yanjun Du, Juan Ni [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 1999-2

Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells

Chezian Somasundaram, Karuna Sundarapandiyan, Tibor Keler [...]

Human Antibodies

Free access

Review article

First published 2017-11

Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness

Ya-Chu Tsai, Tsen-Fang Tsai

Therapeutic Advances in Musculoskeletal Disease

Search results